Biodegradation of sulfamethoxazole: current knowledge and perspectives
Simone Larcher1, Viviane Yargeau
1Department of Chemical Engineering, McGill University, 3610 University Street, Montréal, QC, Canada, H3A 2B2. simone.larcher@mail.mcgill.ca
Applied Microbiology and Biotechnology
|August 18, 2012
Summary
Antibiotic sulfamethoxazole (SMX) is prevalent in aquatic environments, raising concerns about antibiotic resistance. Further research is needed to develop effective biological strategies for removing SMX from wastewater.
Area of Science:
- Environmental Science
- Microbiology
- Chemical Engineering
Background:
- Antibiotic compounds, such as sulfamethoxazole (SMX), are frequently detected in aquatic environments due to widespread use and disposal.
- The presence of SMX in wastewater and surface waters raises concerns regarding the potential development of antibacterial resistance.
- Numerous studies have investigated the environmental fate and persistence of SMX, particularly during wastewater treatment.
Purpose of the Study:
- To review recent developments in the biodegradation and persistence of sulfamethoxazole (SMX) in aquatic environments.
- To identify and discuss discrepancies in existing research findings regarding SMX removal.
- To highlight the need for further research into optimal biological removal strategies for SMX and other antibiotics.
Main Methods:
- Literature review of recent studies on SMX biodegradation and persistence.
- Analysis of data on SMX detection in various water matrices.
- Synthesis of findings related to biological treatment processes for SMX removal.
Main Results:
- SMX is frequently detected in wastewater and surface waters, indicating incomplete removal during treatment.
- There are significant discrepancies in reported biodegradation rates and persistence of SMX across different environmental conditions and treatment systems.
- Current biological removal strategies for SMX show variable effectiveness.
Conclusions:
- The widespread presence of SMX in aquatic ecosystems necessitates improved wastewater treatment methods.
- Further research is crucial to resolve conflicting results and establish effective biological removal strategies for SMX.
- Understanding SMX biodegradation pathways and persistence is key to mitigating the spread of antibiotic resistance in the environment.
Related Concept Videos
01:28Microbial Bioremediation of Pesticides
Pesticides often feature structurally complex chemical architectures, incorporating halogen groups and multiple aromatic rings. These characteristics confer high chemical stability, rendering many pesticides resistant to natural degradation processes. This resistance poses significant environmental concerns, as persistent pesticide residues can accumulate in ecosystems and affect non-target organisms.Despite the inherent stability of many pesticides, certain microorganisms possess the metabolic...
01:28Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
01:16Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:19Factors Affecting Drug Biotransformation: Biological
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...